Dominique Legros

Insider

First SEC filing: March 15, 2018 · Latest: March 15, 2018

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
July 13, 2018	XRAY	A	13	—	—	12,605 Direct	+0.10%	Acquired	(price as of 2026-08-21)
April 13, 2018	XRAY	A	11	—	—	12,593 Direct	+0.09%	Acquired	(price as of 2026-08-21)
March 6, 2018	XRAY	A	12,200	—	—	12,200 Direct	—	Acquired	(price as of 2026-08-21)
March 6, 2018	XRAY	A	2,661	—	—	12,582 Direct	+26.82%	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
March 6, 2018	XRAY	Stock Option (Right to Buy)	Common Stock (12,200)	$56.37	March 6, 2028	12,200	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
March 15, 2018	XRAY	Common Stock	9,920	Direct
March 15, 2018	XRAY	Stock Option (Right to Buy)→ Common Stock (5,300)	5,300	Direct
March 15, 2018	XRAY	Stock Option (Right to Buy)→ Common Stock (5,600)	5,600	Direct
March 15, 2018	XRAY	Stock Option (Right to Buy)→ Common Stock (8,400)	8,400	Direct
March 15, 2018	XRAY	Stock Option (Right to Buy)→ Common Stock (6,500)	6,500	Direct
March 15, 2018	XRAY	Stock Option (Right to Buy)→ Common Stock (6,600)	6,600	Direct
March 15, 2018	XRAY	Stock Option (Right to Buy)→ Common Stock (2,800)	2,800	Direct